The company's purpose is to improve the treatment and care of men with advanced prostate cancer (Advanced Prostate Cancer) on a scientific basis without profit. To this end, the Company undertakes, in particular, the following: organizing conferences on advanced prostate cancer (Advanced Prostate Consensus Conference / APCCC) where shared recommendations on the management of men with advanced prostate cancer are developed; organizing scientific discussion forums for doctors, scientists and other healthcare professionals specializing in prostate cancer; promoting the purpose of the company through other measures, including the development of guidelines; obtaining the necessary resources to achieve the company's goal. The Company may join and maintain relationships with other organizations at home and abroad that pursue the same or similar purpose.